Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer

This study has been completed.
Information provided by (Responsible Party):
KangLaiTe USA Identifier:
First received: August 11, 2008
Last updated: June 17, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)